Moberg Pharma AB (OSTO:MOB) Price-to-Tangible-Book : 12.19 (As of May. 28, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Moberg Pharma AB Price-to-Tangible-Book?

As of today (2024-05-28), Moberg Pharma AB's share price is kr23.90. Moberg Pharma AB's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was kr1.96. Hence, Moberg Pharma AB's Price to Tangible Book Ratio of today is 12.19.

The historical rank and industry rank for Moberg Pharma AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:MOB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.04 Med: 3.32 Max: 15.42
Current: 12.19

During the past 13 years, Moberg Pharma AB's highest Price to Tangible Book Ratio was 15.42. The lowest was 1.04. And the median was 3.32.

OSTO:MOB's Price-to-Tangible-Book is ranked worse than
92.47% of 863 companies
in the Drug Manufacturers industry
Industry Median: 2.32 vs OSTO:MOB: 12.19

A closely related ratio is called PB Ratio. As of today, Moberg Pharma AB's share price is kr23.90. Moberg Pharma AB's Book Value per Sharefor the quarter that ended in Mar. 2024 was kr21.63. Hence, Moberg Pharma AB's P/B Ratio of today is 1.10.

Moberg Pharma AB Price-to-Tangible-Book Historical Data

The historical data trend for Moberg Pharma AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Price-to-Tangible-Book Chart

Moberg Pharma AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.21

1.82

5.41

Moberg Pharma AB Quarterly Data
	Mar19	Jun19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															2.84	1.45	1.62	5.41	11.53

Competitive Comparison of Moberg Pharma AB's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moberg Pharma AB's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Price-to-Tangible-Book falls into.

Moberg Pharma AB Price-to-Tangible-Book Calculation

Moberg Pharma AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	23.90	/	1.96
	=	12.19

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Moberg Pharma AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Moberg Pharma AB (OSTO:MOB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OSTO:MOB) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

MB8:Germany

Address

Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51

Website

https://www.mobergpharma.se

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.